Acquisition synergies Crown Aesthetics is expanding its aesthetics portfolio through the acquisition of Eclipse Medical assets, indicating cross-sell opportunities for complementary devices and skin-care solutions across global markets.

FDA cleared edge The launch of FDA-cleared SkinPen Precision Elite positions Crown Aesthetics as a credible supplier of high-demand microneedling devices, creating upsell and bundle opportunities with existing dermatology and aesthetics clinics.

UK Ireland growth New leadership hire in the UK and Ireland signals a focus on regional market expansion; leverage this to target clinician clients and distributor partnerships for rapid market penetration.

Strategic partnerships Past collaborations with GetHarley and ongoing product launches suggest opportunities to co-market digitally and expand reach through partnerships with digital health platforms and aesthetic clinics.

Customer excellence Award for customer service and a robust tech stack imply strong customer support as a differentiator; use this to upsell premium service plans, training, and maintenance bundles to clinics adopting new devices.